ADC Therapeutics SA Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022
Profitability
Gross Margin 95.89%-2,081.43%
EBT Margin -4,953.08%-105,699.61%-0.74%-73.68%
EBIT Margin -5,102,521.37%-94,225,612.38%-771.65%-58,895.80%
EBITDA Margin -5,102,521.37%-94,225,612.38%-771.65%-58,895.80%
Operating Margin -5,102,521.37%-94,225,612.38%-771.65%-58,895.80%
Net Margin -4,977.95%-105,840.14%-0.68%-74.22%
FCF Margin -0.10%-5,247,735.04%-72,853,459.39%-698.20%-66,218.53%
Efficiency
Inventory Average 11.60M
Assets Average 554.42M
Equity Average 39.81M
Invested Capital 23.90M431.67M506.28M
Asset Utilization Ratio 0.00
Leverage & Solvency
Interest Coverage Ratio 39.80M81.21M100.66M
Debt to Equity 564.331.54
Debt Ratio 0.150.25
Equity Ratio 0.810.000.16
Times Interest Earned 39.80M81.21M100.66M
Valuation
Enterprise Value -115.55M2,269.97M1,083.60M-36.77M
Market Capitalization 2,269.97M1,550.14M289.67M
Return Ratios
Return on Sales -49.28%-0.01%-0.73%
Return on Capital Employed -0.26%
Return on Invested Capital -0.26%
Return on Assets 0.00%
Return on Equity 0.00%